-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Humana, Raises Price Target to $475

Benzinga·10/09/2026 14:04:58
Listen to the news
Oppenheimer analyst Michael Wiederhorn maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $405 to $475.